Date: September 2027

Location: Europe

Join the Biochemical Society’s 2027 PI3K Meeting, returning after a successful previous edition to showcase the latest breakthroughs in PI3K pathway biology, signalling and therapeutic targeting. The programme will highlight PI3Ks and pathway regulation (PTEN, AKT, mTOR, RAS), emerging drug strategies, and insights from rare PI3K-driven disorders, among other topics. Bringing together leading basic, translational, clinical, and industry experts, this focused international meeting will foster collaboration, address renewed interest and opportunities in developing novel therapeutics, and to inspire the next generation of researchers in this rapidly advancing field. Ample opportunities will be provided for oral presentations of submitted abstracts – early bird registration ends.